Meet the "Triple Threat" peptide that's turning heads in healthcare.
The EPG drama unfolds with a lawsuit against David Protein Bars.
Clash impeding from RFK and FDA on reversing a decade-long ban on peptides.
The Moody Longevity Trial kicks-off with blockbuster diabetes drug at the center.
Ultrahuman debuts migraine management partnership with Click Therapeutics.
Study of 26,000 adults found a surprising link between creatine and oncology.
Why skipping leg day might be costing you more than just muscle.
The most important clinical studies, highlights, and moments of the year.
25-year study shows substantial brain benefits in consuming high-fat cheese. Go ahead and pass the brie!
What science says about creativity and slowing down the age clock.
When the clinical data is strong, but the methodology is weak. Inside the latest trial offering to re-set the epigenetic clock by 5-years.
The roadmap to navigating BF/CM.
Music and brain health, Cymbiotika heads for expansion, and coffee continues it's hot streak.
Should you be taking Alpha-GPC, the app that big food hates, and the not-so-suprising reserach on artificial sweeteners.
Hims & Hers targets menopause market, charred foods might be harmful, and the lymphatic drainage trick you can try at home.
The bombshell investigative protein report, Altos Labs makes progress, and strength training still reigns supreme.
Red light therapy for your gums, Eudomonia Summit unveils a jam-packed roster, and the impact of plastic water bottles.
A showdown in male fertility, MoldCo scores funding, and OneMedical launches nationwide menopause care.
Cocoa shows clinical benefits, Pulse drops Whoop competitor, and creatine delivers cardiovascular aid.
The importance of meal timing for longevity, RFK goes after tylenol, and Super Mush steps into creatine.
Whoop for your poop, the musical instrument learning hack, and why mindset is a critical component of extending lifespan.
Foods that age you faster, the suprising face of GLP-1s, and nicotine hits the beverage aisle.
RAADfest ends in a health scare, FountainLife nabs $18M, and everybody's talking about Man Cereal.
Lithium shows reversal in memory loss, OneSkin nabs $20M, and the Human Phenotype Project rolls on.
